145 related articles for article (PubMed ID: 37897815)
1. Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.
Rodgers-Fouche L; Arora S; Ricker C; Li D; Farooqi M; Balaguer F; Dominguez-Valentin M; Guillem JG; Kanth P; Liska D; Melson J; Mraz KA; Shirts BH; Vilar E; Katona BW; Hodan R
JCO Precis Oncol; 2023 Sep; 7():e2300440. PubMed ID: 37897815
[TBL] [Abstract][Full Text] [Related]
2. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
[TBL] [Abstract][Full Text] [Related]
3. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.
Heald B; Hampel H; Church J; Dudley B; Hall MJ; Mork ME; Singh A; Stoffel E; Stoll J; You YN; Yurgelun MB; Kupfer SS;
Fam Cancer; 2020 Jul; 19(3):223-239. PubMed ID: 32172433
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.
Moretz C; Byfield SD; Hatchell KE; Dalton J; Onglao PN; Hang L; Hansen P; Radford C; Nielsen SM; Heald B; Munro SB; Nussbaum RL; Esplin ED
JAMA Netw Open; 2022 Oct; 5(10):e2238167. PubMed ID: 36279135
[TBL] [Abstract][Full Text] [Related]
5. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
[TBL] [Abstract][Full Text] [Related]
6. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program.
You YN; Moskowitz JB; Chang GJ; Mork ME; Rodriguez-Bigas MA; Bednarski BK; Messick CA; Tillman MM; Skibber JM; Nguyen ST; Kopetz S; Vilar E
Dis Colon Rectum; 2023 Apr; 66(4):531-542. PubMed ID: 35195555
[TBL] [Abstract][Full Text] [Related]
7. Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
Jiang W; Li L; Ke CF; Wang W; Xiao BY; Kong LH; Tang JH; Li Y; Wu XD; Hu Y; Guo WH; Wang SZ; Wan DS; Xu RH; Pan ZZ; Ding PR
J Med Genet; 2022 Apr; 59(4):370-376. PubMed ID: 33563768
[TBL] [Abstract][Full Text] [Related]
8. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
[TBL] [Abstract][Full Text] [Related]
9. Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study.
Noll A; J Parekh P; Zhou M; Weber TK; Ahnen D; Wu XC; Karlitz JJ
Clin Transl Gastroenterol; 2018 Sep; 9(9):185. PubMed ID: 30237431
[TBL] [Abstract][Full Text] [Related]
10. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
[TBL] [Abstract][Full Text] [Related]
11. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.
Weissman SM; Burt R; Church J; Erdman S; Hampel H; Holter S; Jasperson K; Kalady MF; Haidle JL; Lynch HT; Palaniappan S; Wise PE; Senter L
J Genet Couns; 2012 Aug; 21(4):484-93. PubMed ID: 22167527
[TBL] [Abstract][Full Text] [Related]
12. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing for colorectal carcinoma susceptibility: focus group responses of individuals with colorectal carcinoma and first-degree relatives.
Kinney AY; DeVellis BM; Skrzynia C; Millikan R
Cancer; 2001 Jan; 91(1):57-65. PubMed ID: 11148560
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Holter S; Hall MJ; Hampel H; Jasperson K; Kupfer SS; Larsen Haidle J; Mork ME; Palaniapppan S; Senter L; Stoffel EM; Weissman SM; Yurgelun MB
J Genet Couns; 2022 Jun; 31(3):568-583. PubMed ID: 35001450
[TBL] [Abstract][Full Text] [Related]
15. Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent.
Subramonian A; Smith D; Dicks E; Dawson L; Borgaonkar M; Etchegary H
Per Med; 2020 Sep; 17(5):373-387. PubMed ID: 32875945
[No Abstract] [Full Text] [Related]
16. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
Uson PLS; Riegert-Johnson D; Boardman L; Kisiel J; Mountjoy L; Patel N; Lizaola-Mayo B; Borad MJ; Ahn D; Sonbol MB; Jones J; Leighton JA; Gurudu S; Singh H; Klint M; Kunze KL; Golafshar MA; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab TS; Jewel Samadder N
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e508-e528. PubMed ID: 33857637
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.
Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST
Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634
[TBL] [Abstract][Full Text] [Related]
18. Exploring Breast Surgeons' Attitudes on Universal Genetic Testing: A Qualitative Study.
Lapkus M; Horowitz B; Sauer C; Victorson D; Poli E; Smith TW; Kopkash K; Yao K; Pesce C
Ann Surg Oncol; 2023 Oct; 30(10):6108-6116. PubMed ID: 37439952
[TBL] [Abstract][Full Text] [Related]
19. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
Vasen HF; Möslein G; Alonso A; Aretz S; Bernstein I; Bertario L; Blanco I; Bulow S; Burn J; Capella G; Colas C; Engel C; Frayling I; Rahner N; Hes FJ; Hodgson S; Mecklin JP; Møller P; Myrhøj T; Nagengast FM; Parc Y; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen J; Lubinski J; Järvinen H; Claes E; Heinimann K; Karagiannis JA; Lindblom A; Dove-Edwin I; Müller H
Fam Cancer; 2010 Jun; 9(2):109-15. PubMed ID: 19763885
[TBL] [Abstract][Full Text] [Related]
20. Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.
Muller C; Lee SM; Barge W; Siddique SM; Berera S; Wideroff G; Tondon R; Chang J; Peterson M; Stoll J; Katona BW; Sussman DA; Melson J; Kupfer SS
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1911-1918.e2. PubMed ID: 30130624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
